| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.08▼ | 1.08▼ | 1.08▼ | 1.11▼ | 1.13▼ |
| MA10 | 1.09▼ | 1.10▼ | 1.10▼ | 1.16▼ | 1.04▲ |
| MA20 | 1.11▼ | 1.12▼ | 1.12▼ | 1.15▼ | 1.09▼ |
| MA50 | 1.11▼ | 1.14▼ | 1.17▼ | 1.06▲ | 1.15▼ |
| MA100 | 1.17▼ | 1.21▼ | 1.16▼ | 1.10▼ | 3.08▼ |
| MA200 | 1.22▼ | 1.09▼ | 1.04▲ | 1.19▼ | 146,927.71▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.003▼ | -0.002▼ | -0.019▼ | 1.295▲ |
| RSI | 36.097▼ | 37.230▼ | 37.180▼ | 46.567▼ | 24.496▼ |
| STOCH | 14.039▼ | 6.980▼ | 6.170▼ | 16.498▼ | 56.331 |
| WILL %R | -93.750▼ | -93.750▼ | -93.750▼ | -91.892▼ | -52.607 |
| CCI | -100.575▼ | -108.889▼ | -113.725▼ | -96.597 | 18.231 |
|
Wednesday, March 25, 2026 04:07 AM
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Allstate (NYSE:ALL) and the best and worst ...
|
|
Tuesday, March 24, 2026 08:37 PM
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Allstate (NYSE:ALL) and the best and worst ...
|
|
Wednesday, February 18, 2026 05:15 AM
TARPON SPRINGS, Fla., February 18, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/03/26 | 1.11 | 1.11 | 1.07 | 1.075 | 83,187 |
| 25/03/26 | 1.13 | 1.17 | 1.10 | 1.12 | 62,668 |
| 24/03/26 | 1.13 | 1.16 | 1.07 | 1.12 | 105,376 |
| 23/03/26 | 1.10 | 1.16 | 1.075 | 1.14 | 103,356 |
| 20/03/26 | 1.10 | 1.118 | 1.045 | 1.08 | 177,204 |
| 19/03/26 | 1.16 | 1.1799 | 1.08 | 1.10 | 161,857 |
| 18/03/26 | 1.26 | 1.26 | 1.14 | 1.17 | 105,570 |
| 17/03/26 | 1.28 | 1.3302 | 1.24 | 1.25 | 113,984 |
| 16/03/26 | 1.25 | 1.305 | 1.23 | 1.28 | 150,300 |
| 13/03/26 | 1.37 | 1.37 | 1.25 | 1.26 | 123,683 |
|
|
||||
|
|
||||
|
|